Targeted Therapy Extends Survival in Cancers of Unknown Primary

Targeted Therapy Extends Survival in Cancers of Unknown Primary In the complex and often bewildering world of oncology, few challenges are as perplexing as cancers of unknown primary origin (CUP). These enigmatic cases occur when metastatic cancer is identified, but the original tumor site remains hidden. Accounting for approximately 2-5% of all cancer diagnoses, CUP […]